Press Releases - 2021-10-05
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
Press Releases - 2021-08-17
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
Press Releases - 2021-08-13
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
Press Releases - 2021-08-11
Wholly Owned Pipeline - LYT-503/IMB-150
Wholly Owned Pipeline - LYT-100
PureTech Announces that Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome